E53G (p.Glu53Gly) variant of CDC73 (Parafibromin)

E53G (p.Glu53Gly) in CDC73 (Parafibromin) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Parathyroid carcinoma. The available variant effect predictions contribute to a CATVariant prioritization score of 0.77 / 1. The record also includes population frequency data, published literature, and structural context.

E53G (p.Glu53Gly) variant details